Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Deranged NMDAergic cortico-subthalamic transmission underlies parkinsonian motor deficits
Ming-Kai Pan, Chun-Hwei Tai, Wen-Chuan Liu, Ju-Chun Pei, Wen-Sung Lai, Chung-Chin Kuo
Ming-Kai Pan, Chun-Hwei Tai, Wen-Chuan Liu, Ju-Chun Pei, Wen-Sung Lai, Chung-Chin Kuo
View: Text | PDF
Research Article Neuroscience

Deranged NMDAergic cortico-subthalamic transmission underlies parkinsonian motor deficits

  • Text
  • PDF
Abstract

Parkinson’s disease (PD) is the most prevalent hypokinetic movement disorder, and symptomatic PD pathogenesis has been ascribed to imbalances between the direct and indirect pathways in the basal ganglia circuitry. Here, we applied glutamate receptor blockers to the subthalamic nucleus (STN) of parkinsonian rats and evaluated locomotor behaviors via single-unit and local-field recordings. Using this model, we found that inhibition of NMDAergic cortico-subthalamic transmission ameliorates parkinsonian motor deficits without eliciting any vivid turning behavior and abolishes electrophysiological abnormalities, including excessive subthalamic bursts, cortico-subthalamic synchronization, and in situ beta synchronization in both the motor cortex and STN. Premotor cortex stimulation revealed that cortico-subthalamic transmission is deranged in PD and directly responsible for the excessive stimulation-dependent bursts and time-locked spikes in the STN, explaining the genesis of PD-associated pathological bursts and synchronization, respectively. Moreover, application of a dopaminergic agent via a microinfusion cannula localized the therapeutic effect to the STN, without correcting striatal dopamine deficiency. Finally, optogenetic overactivation and synchronization of cortico-subthalamic transmission alone sufficiently and instantaneously induced parkinsonian-associated locomotor dysfunction in normal mice. In addition to the classic theory emphasizing the direct-indirect pathways, our data suggest that deranged cortico-subthalamic transmission via the NMDA receptor also plays a central role in the pathophysiology of parkinsonian motor deficits.

Authors

Ming-Kai Pan, Chun-Hwei Tai, Wen-Chuan Liu, Ju-Chun Pei, Wen-Sung Lai, Chung-Chin Kuo

×

Figure 4

Effect of glutamate receptor antagonists on cortico-subthalamic beta synchronization.

Options: View larger image (or click on image) Download as PowerPoint
Effect of glutamate receptor antagonists on cortico-subthalamic beta syn...
Electrical activity in the low-frequency range was simultaneously recorded in the premotor cortex and STN, and frequency-dependent synchronizations were quantified by coherence analysis. (A) Raw sweeps of electrical activity simultaneously recorded in the premotor cortex and STN. (B) Time-frequency coherence plot of cortico-subthalamic synchronization. Subthalamic AP5 microinfusion started at 780 seconds (13 minutes) and lasted 300 seconds (5 minutes; gray bar at top of the plot). The total recording lasted 1 hour. Note the band of synchronization at beta frequencies (20–40 Hz) at baseline and that AP5 readily abolished beta synchronization. (C) CGS has an effect similar to that of AP5. (D) CNQX did not change the coherence in beta frequencies. (E) There was no synchronization of beta frequencies in a normal rat. (F) Quantitative measurement of coherence of beta frequencies. Coherence was significantly different between normal and parkinsonian rats (n = 13 different rats for each group; P = 0.001). (G) Quantitative measurement of the drug effect in parkinsonian rats. Coherence of beta frequencies was significantly suppressed by AP5 (n = 12, P = 0.002) and CGS (n = 9, P = 0.008), while CNQX (n = 8, P = 0.575) did not have such an effect. Statistical analyses were performed using a nonparametric Wilcoxon signed-rank test. Data represent the mean ± SEM. **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts